Evidence map›Paper›PMID 42726233›Full record

ArticleAnalytical and bioanalytical chemistry2026

Dual template (epitope) imprinting of Mycobacterium leprae bacterial protein for enhanced MIP-EQCM sensing.

Moumita Mandal, Akriti Srivastava, Tulika Rai, Meenakshi Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Moumita MandalDepartment of Chemistry, Mahila Mahavidyalaya (MMV), Varanasi, India.
Akriti SrivastavaDepartment of Chemistry, Mahila Mahavidyalaya (MMV), Varanasi, India.
Tulika RaiDepartment of Dermatology and Venereology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.
Meenakshi SinghDepartment of Chemistry, Mahila Mahavidyalaya (MMV), Varanasi, India. meenakshi@bhu.ac.in.ORCID http://orcid.org/0000-0002-5909-8757

Funding

Banaras Hindu University IoE 6031University Grants Commission 220510278819
6 · The paper itself

Abstract

Leprosy, often known as Hansen's disease, is a chronic bacterial infection caused by Mycobacterium leprae (M. leprae) bacteria. The bacterium has a long incubation period, making it challenging for diagnosis. Timely diagnosis is crucial in initiating early treatment and preventing disease progression and complications. Herein, we proposed a dual-epitope imprinted polymer sensor for M. leprae bacterial protein. Two peptide (epitope) sequences unique to the bacteria were selected and immobilized onto gold nanoparticles, followed by polymerization using multiple monomers 2-methacryloyloxyethyl phosphorylcholine (2-MPC), benzyl methacrylate (BM), and 4-aminothiophenol (4-ATP), selected through in silico molecular docking strategy and ethylene glycol dimethacrylate (EGDMA) as a cross-linker. The imprinted polymer was electrodeposited on the gold coated electrochemical quartz crystal microbalance (EQCM) electrode. The sensor was able to show specific binding towards the real blood samples of leprosy patients. The limit of detection (1.39-1.82 nM) and limit of quantification (4.20-5.51 nM) with no cross reactivity and matrix effect indicate high sensitivity and selectivity. The sensor exhibits a significant improvement in selectivity and adsorption capacity over conventional sensors, with add-on advantages of reusability, high selectivity and sensitivity.

Indexed as

Antibody-free diagnosticsBacterial proteinDual template imprintingEpitope imprintingMolecularly imprinted polymerMycobacterium leprae

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.